Search
- Report
Chapin White, CBO's Director of Health Analysis, testifies before the House Energy and Commerce Committee's Subcommittee on Health.
- Report
Learn more about CBO, its work, and its processes in an introduction to the agency that is typically updated at the start of each Congress or a new session.
- Report
CBO reports annually on programs whose authorizations of appropriations have already expired or will expire. This data file covers legislation enacted through September 30, 2023. A full report will be issued later this year.
- Report
CBO provides information concerning implementation of the caps on most discretionary funding for fiscal year 2024 as established by the Fiscal Responsibility Act of 2023.
- Cost Estimate
As ordered reported by the House Committee on Ways and Means on September 28, 2023
- Report
The Senate Committee on the Budget convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Presentation
Presentation by Lara Robillard, an analyst in CBO’s Budget Analysis Division, at AcademyHealth’s 2023 Health Policy Orientation, "Information Sources for Policymaking."
- Report
CBO’s Director of Health Analysis, Chapin White, testifies on alternative payment models and the slowdown in federal health care spending.
- Blog Post
To enhance its work for the Congress, CBO is looking for new research on factors that affect the use of anti-obesity medications and the impact of that use on other health care spending.
- Report
CBO estimates that the Center for Medicare & Medicaid Innovation’s (CMMI’s) activities increased federal spending between 2011 and 2020 and will also increase it from 2021 to 2030. In 2010, CBO projected that CMMI would produce savings.